mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.002 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.003 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |